Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.

Documenti analoghi

• Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
  di: Becker, C, et al.
  Pubblicazione: (2003)
• Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater.
  di: Becker, C, et al.
  Pubblicazione: (2000)
• Sensitive and specific immunodetection of human glandular kallikrein 2 in serum.
  di: Becker, C, et al.
  Pubblicazione: (2000)
• Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
  di: Steuber, T, et al.
  Pubblicazione: (2005)
• Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
  di: Becker, C, et al.
  Pubblicazione: (2000)